Which combination is listed as a 'false positives' pairing?

Prepare for the PMHNP Certification Exam with targeted questions and expert explanations. Master the topics with insights into the exam format and key strategies to succeed.

Multiple Choice

Which combination is listed as a 'false positives' pairing?

Explanation:
The idea being tested is identifying a pairing that is labeled as a false-positive in screening contexts. In the study resources for this PMHNP exam, a combination involving a benzodiazepine and Zoloft (sertraline) is listed as a false-positive pairing. The rationale is that certain lab screening immunoassays can cross-react with sertraline or its metabolites, producing a spurious positive result for benzodiazepines even if a benzodiazepine isn’t actually present. That labeling signals you should not rely on a positive screen to confirm the presence of a benzodiazepine when sertraline is part of the regimen. The other options do not carry that false-positive flag in the materials. Two SSRIs together are a clinically discussed combination with risks (like serotonin syndrome) but not a false-positive labeling in this context; a benzodiazepine with Celexa is another benzo-SSRI pairing without that specific screening interference tag; and Benadryl with Zoloft is simply an antihistamine-SSRI combo without the false-positive designation in the resource. So, the benzodiazepine with Zoloft pairing stands out as the one listed as a false-positive pairing.

The idea being tested is identifying a pairing that is labeled as a false-positive in screening contexts. In the study resources for this PMHNP exam, a combination involving a benzodiazepine and Zoloft (sertraline) is listed as a false-positive pairing. The rationale is that certain lab screening immunoassays can cross-react with sertraline or its metabolites, producing a spurious positive result for benzodiazepines even if a benzodiazepine isn’t actually present. That labeling signals you should not rely on a positive screen to confirm the presence of a benzodiazepine when sertraline is part of the regimen.

The other options do not carry that false-positive flag in the materials. Two SSRIs together are a clinically discussed combination with risks (like serotonin syndrome) but not a false-positive labeling in this context; a benzodiazepine with Celexa is another benzo-SSRI pairing without that specific screening interference tag; and Benadryl with Zoloft is simply an antihistamine-SSRI combo without the false-positive designation in the resource.

So, the benzodiazepine with Zoloft pairing stands out as the one listed as a false-positive pairing.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy